These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
257 related items for PubMed ID: 26503156
1. Expression of retinoic acid-binding proteins and retinoic acid receptors in sebaceous cell carcinoma of the eyelids. Tsai YJ, Wu SY, Huang HY, Ma DH, Wang NK, Hsiao CH, Cheng CY, Yeh LK. BMC Ophthalmol; 2015 Oct 26; 15():142. PubMed ID: 26503156 [Abstract] [Full Text] [Related]
2. Expression of retinoid receptors in sebaceous cell carcinoma. Chakravarti N, El-Naggar AK, Lotan R, Anderson J, Diwan AH, Saadati HG, Diba R, Prieto VG, Esmaeli B. J Cutan Pathol; 2006 Jan 26; 33(1):10-7. PubMed ID: 16441406 [Abstract] [Full Text] [Related]
4. Dynamic regulation of retinoic acid-binding proteins in developing, adult and neoplastic skin reveals roles for beta-catenin and Notch signalling. Collins CA, Watt FM. Dev Biol; 2008 Dec 01; 324(1):55-67. PubMed ID: 18805411 [Abstract] [Full Text] [Related]
5. Cancer Stem Cell Markers in Eyelid Sebaceous Gland Carcinoma: High Expression of ALDH1, CD133, and ABCG2 Correlates With Poor Prognosis. Kim N, Choung HK, Lee MJ, Khwarg SI, Kim JE. Invest Ophthalmol Vis Sci; 2015 Feb 24; 56(3):1813-9. PubMed ID: 25711631 [Abstract] [Full Text] [Related]
6. Sebaceous gland carcinoma of the ocular adnexa - variability in clinical and histological appearance with analysis of immunohistochemical staining patterns. Schmitz EJ, Herwig-Carl MC, Holz FG, Loeffler KU. Graefes Arch Clin Exp Ophthalmol; 2017 Nov 24; 255(11):2277-2285. PubMed ID: 28741159 [Abstract] [Full Text] [Related]
7. Clinicopathological features of considerable reduction in androgen receptor expression in sebaceous gland carcinoma of the eyelid. Yunoki T, Miyakoshi A, Otsuka M, Hayashi A. Int Ophthalmol; 2019 Aug 24; 39(8):1703-1708. PubMed ID: 30027448 [Abstract] [Full Text] [Related]
8. E-cadherin and β-catenin expression in sebaceous eyelid adenocarcinomas. Li L, Zhang Z, Li B, Gao F, Li L, Jonas JB. Graefes Arch Clin Exp Ophthalmol; 2011 Dec 24; 249(12):1867-73. PubMed ID: 21739269 [Abstract] [Full Text] [Related]
9. Does β-catenin have a role in pathogenesis of sebaceous cell carcinoma of the eyelid? Jayaraj P, Sen S, Kashyap S, Sharma A, Pushker N, Bajaj MS, Ghose S, Chosdol K. Br J Ophthalmol; 2011 Feb 24; 95(2):284-7. PubMed ID: 20813740 [Abstract] [Full Text] [Related]
10. Expression of alpha-crystallins in human sebaceous carcinoma of the eyelid. Rigas PK, Kase S, Rao NA. Eur J Ophthalmol; 2009 Feb 24; 19(5):702-7. PubMed ID: 19787585 [Abstract] [Full Text] [Related]
11. Increased gene copy number of HER2 and concordant protein overexpression found in a subset of eyelid sebaceous gland carcinoma indicate HER2 as a potential therapeutic target. Lee MJ, Kim N, Choung HK, Choe JY, Khwarg SI, Kim JE. J Cancer Res Clin Oncol; 2016 Jan 24; 142(1):125-33. PubMed ID: 26141290 [Abstract] [Full Text] [Related]
16. Eyelid sebaceous carcinoma: clinicopathologic and multiparametric immunohistochemical analysis that includes adipophilin. Jakobiec FA, Mendoza PR. Am J Ophthalmol; 2014 Jan 24; 157(1):186-208.e2. PubMed ID: 24112633 [Abstract] [Full Text] [Related]
17. Sebaceoma of the eyelid. Yonekawa Y, Jakobiec FA, Zakka FR, Fay A. Ophthalmology; 2012 Dec 24; 119(12):2645.e1-4. PubMed ID: 23207023 [No Abstract] [Full Text] [Related]
18. Clinical relevance of cyclooxygenase 2 and peroxisome proliferator-activated receptor γ in eyelid sebaceous gland carcinoma. Jayaraj P, Sen S, Bhattacharya T, Arora J, Yadav S, Chhoker V, Kumar A, Dhanaraj PS, Yadavilli KS, Verma M. Histopathology; 2016 Aug 24; 69(2):268-75. PubMed ID: 26791964 [Abstract] [Full Text] [Related]
19. CDKN2A, CDK1, and CCNE1 overexpression in sebaceous gland carcinoma of eyelid. Yunoki T, Hirano T, Tabuchi Y, Furusawa Y, Torigoe M, Nakajima T, Imura J, Hayashi A. Int Ophthalmol; 2020 Feb 24; 40(2):343-350. PubMed ID: 31571090 [Abstract] [Full Text] [Related]